Ultime notizie per Mene (OTC:MENEF) Azioni

Mene Inc crafts pure 24-karat gold and platinum jewelry that is transparently sold by gram weight through mene.com, customers may buy jewelry, monitor the value of their collection, and sell or exchange their pieces by gram weight at prevailing market prices. The company retails its jewelry by gram weight direct-to-consumer through an online shopping experience.

Mene Inc

Needham analyst Gil Blum maintains Nurix Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NRIX#NASDAQ">NRIX</a>) with a Buy and lowers the price target from $28 to $27.

News

Price Target

Analyst Ratings

NRIX

Needham Maintains Buy on Nurix Therapeutics, Lowers Price Target to $27

<a href="https://ec.europa.eu/commission/presscorner/detail/es/statement_25_1025" title="https://ec.europa.eu/commission/presscorner/detail/es/statement_25_1025">https://ec.europa.eu/commission/presscorner/detail/es/statement_25_1025</a>

Government

Macro Economic Events

Politics

Economics

General

EU Commission Says It Will Impose First Countermeasures Against U.S. Tariffs On April 15; Says It Secures Backing From Eu Countries For First Countermeasures Against Us Tariffs; Says Countermeasures Can Be Suspended At Any Time, Should The US Agree To A Fair And Balanced Negotiated Outcome

Mizuho analyst Nitin Kumar maintains Delek US Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DK#NYSE">DK</a>) with a Neutral and lowers the price target from $25 to $22.

Mizuho Maintains Neutral on Delek US Hldgs, Lowers Price Target to $22

Wells Fargo analyst Timur Braziler upgrades First BanCorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FBP#NYSE">FBP</a>) from Equal-Weight to Overweight and announces $20 price target.

Upgrades

Wells Fargo Upgrades First BanCorp to Overweight, Announces $20 Price Target

Ray Dalio may no longer be steering the investment ship at Bridgewater Associates, but his recent warning on X has left little doubt about <a href="https://www.benzinga.com/topic/ray-dalio">where he thinks</a> the world is headed. 
"We're witnessing a classic breakdown of the major monetary, political, and geopolitical orders," Dalio wrote, calling it a "once in a lifetime" phenomenon, the kind that "has happened many times in history, when similarly unsustainable conditions were in place."
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">At the moment, a huge amount of attention is rightly being paid to the newly announced tariffs and their significant impacts on markets and economies. But very little attention is being paid to the circumstances that caused them—and to the even bigger disruptions likely still… <a href="https://t.co/wPIgzDscbk">https://t.co/wPIgzDscbk</a>
&mdash; Ray Dalio (@RayDalio) <a href="https://twitter.com/RayDalio/status/1909296359955460347?ref_src=twsrc%5Etfw">April 7, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The spark? Tariffs. But the fire, Dalio says, runs deeper.
&#8220;These tariff announcements are important developments. But most people are overlooking the much larger forces that are driving just about everything," Dalio said.
While he's not actively managing the fund, Bridgewater's latest 13F filing offers a glimpse into how the firm is positioning itself in the face of this macro upheaval.
Read Also: <a href="https://www.benzinga.com/government/regulations/25/04/44707736/expert-warns-of-perfect-storm-as-trump-tariffs-slam-global-stock-markets-advises-investors-to-seek-safety-in-gold-and-fixed-income-instruments">Expert Warns Of &#8216;Perfect Storm&#8217; As Trump Tariffs Slam Global Stock Markets — Advises Investors To Seek Safety In Gold And Fixed-Income Instruments</a>
<h2 class="wp-block-heading">Tariffs, Turmoil And A Bet On The Index</h2>
Despite Dalio's big-picture warning, Bridgewater's top holding as of the fourth quarter of 2024 was the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>)—now a whopping 22.1% of the portfolio. Add iShares Core S&amp;P 500 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IVV#NYSE">IVV</a>) and iShares Emerging Markets (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IEMG#NYSE">IEMG</a>) and nearly half the firm's equity book is riding broad indices.
That's a defensive play wrapped in passive exposure, especially as markets wobble under new trade war concerns.
The fund didn't stop there. Among its top new buys were AT&amp;T Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/T#NYSE">T</a>), eBay Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EBAY#NASDAQ">EBAY</a>) and PayPal Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYPL#NASDAQ">PYPL</a>) &#8211; low-multiple names that look like classic recession hedges.
Applovin Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APP#NASDAQ">APP</a>) also made the list, a curious pick that may reflect a contrarian bet on adtech amid volatility.
<h2 class="wp-block-heading">From Tech Titans To Utility Muscle</h2>
Bridgewater has trimmed back tech allocations to the sector, which fell from 19.8% to 16.3% quarter over quarter. Still, it holds heavyweights like Alphabet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>), Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) and Microsoft Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), albeit at lower portfolio weights than before.
Meanwhile, two quiet climbers in the portfolio are worth noting: Constellation Energy Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEG#NASDAQ">CEG</a>) and Vistra Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VST#NYSE">VST</a>), both utility players sitting comfortably in the top 10 holdings. In a world Dalio sees veering toward chaos, old-school stability may be back in fashion.
<h2 class="wp-block-heading">Macro Chaos, Micro Calculations</h2>
Dalio's post paints a stark picture of structural breakdown—"unsustainable conditions" colliding with a new era of tariffs and geopolitical chess. While Bridgewater's allocations don't scream panic, the tilt toward broad ETFs, dividend-value names and utilities suggests the firm is bracing for bumps ahead.
Whether or not the VUCA (Volatile, Uncertain, Complex, Ambiguous) world Dalio describes becomes a reality, Bridgewater seems to be preparing for the long game &#8211; passive on the surface but deeply macro-aware under the hood.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/social-media/25/04/44705344/ray-dalio-says-dont-make-the-mistake-of-thinking-whats-happening-now-is-due-to-trump-tariffs">Ray Dalio Says Don&#8217;t Make The Mistake Of Thinking What&#8217;s Happening Now Is Due To Trump Tariffs</a></li>
</ul>
Photo: Shutterstock

Long Ideas

Broad U.S. Equity ETFs

Emerging Market ETFs

Trading Ideas

ETFs

EBAY

GOOG

GOOGL

IEMG

MSFT

NVDA

PYPL

Here's Where Bridgewater Is Placing Its Bets As Ray Dalio Warns Of 'Once-In-A-Lifetime' Breakdown

BTTR

Better Choice Company Regains Compliance With NYSE American Continued Listing Standards

Mizuho analyst Nitin Kumar maintains Phillips 66 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSX#NYSE">PSX</a>) with a Neutral and lowers the price target from $140 to $132.

Mizuho Maintains Neutral on Phillips 66, Lowers Price Target to $132

Wells Fargo analyst Timur Braziler upgrades Popular (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BPOP#NASDAQ">BPOP</a>) from Equal-Weight to Overweight and lowers the price target from $110 to $100.

BPOP

Wells Fargo Upgrades Popular to Overweight, Lowers Price Target to $100

<a href="https://www.tradingview.com/news/reuters.com,2025:newsml_S0N3Q700W:0-fed-s-kashkari-neither-rate-hike-nor-cut-is-off-the-table-hurdle-is-high-for-both/" title="https://www.tradingview.com/news/reuters.com,2025:newsml_S0N3Q700W:0-fed-s-kashkari-neither-rate-hike-nor-cut-is-off-the-table-hurdle-is-high-for-both/">https://www.tradingview.com/news/reuters.com,2025:newsml_S0N3Q700W:0-fed-s-kashkari-neither-rate-hike-nor-cut-is-off-the-table-hurdle-is-high-for-both/</a>

Federal Reserve

Fed's Kashkari Says First Priority Must Be Keeping Long-run Inflation Expectations Anchored;  Announced Tariffs Much Higher, Broader Than Expected, Resulting In Larger Economic Effect And Shock To Confidence; Near-term Inflation Will Climb, Purchasing Power Will Go Down, Investment Will Likely Be Lower, GDP Will Be Smaller Due To Tariffs; Once Confident On Inflation Expectations, Could Then Focus On Trade-offs Between Goals

Needham analyst Mike Matson reiterates InMode (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INMD#NASDAQ">INMD</a>) from Hold to Hold.

Reiteration

INMD

Needham Reiterates Hold on InModeto Hold

Wells Fargo analyst Elyse Greenspan downgrades WR Berkley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WRB#NYSE">WRB</a>) from Overweight to Equal-Weight and lowers the price target from $70 to $69.

Downgrades

Wells Fargo Downgrades WR Berkley to Equal-Weight, Lowers Price Target to $69

Fed's Kashkari Says No Monetary Policy Response, Up Or Down, Should Be Off The Table; Hurdle To Changing Policy Rate Has Increased Due To Tariffs; Bar Is Higher For Cutting Rates Even If Economy, Labor Market Weakens; Falling Neutral Rate Due To Tariffs Reduces Immediate Need For Rate Hike; Risk Of Unanchoring Inflation Expectations Seems To Have Increased Notably; 'Too Risky' To Look Through Inflation Effects Of Tariffs

In response to ongoing market uncertainty, PacBio is executing a plan to reduce both headcount across all functions and non-headcount related expenses to lower its annualized non-GAAP operating expense run-rate by $45 million to $50 million by year end in relation to its prior guidance of $270 million to $280 million. Following the reductions, PacBio aims to focus on its highest-impact long-read platform development initiatives.&nbsp;

Management

PACB

PacBio Says In Response To Ongoing Market Uncertainty, PacBio Is Executing A Plan To Reduce Both Headcount Across All Functions And Non-Headcount Related Expenses To Lower Its Annualized Non-GAAP Operating Expense Run-Rate By $45M-$50M

<h3>Gainers</h3>
<table>
<thead>
<tr>
<th>Symbol</th>
<th>Name</th>
<th align="right">Price</th>
<th align="right">Change ($)</th>
<th align="right">Change (%)</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>)</td>
<td>SPDR Select Sector Fund - Technology</td>
<td align="right">180.66</td>
<td align="right">0.93</td>
<td align="right">0.51</td>
<td>193.6K</td>
</tr>
</tbody>
</table>
<h3>Losers</h3>
<table>
<thead>
<tr>
<th>Symbol</th>
<th>Name</th>
<th align="right">Price</th>
<th align="right">Change ($)</th>
<th align="right">Change (%)</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLRE#NYSE">XLRE</a>)</td>
<td>Real Estate Select Sector SPDR Fund (The)</td>
<td align="right">36.29</td>
<td align="right">-0.79</td>
<td align="right">-2.14</td>
<td>16.7K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLV#NYSE">XLV</a>)</td>
<td>SPDR Select Sector Fund - Health Care</td>
<td align="right">130.47</td>
<td align="right">-2.51</td>
<td align="right">-1.89</td>
<td>54.5K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>)</td>
<td>SPDR Select Sector Fund - Energy Select Sector</td>
<td align="right">75.40</td>
<td align="right">-1.04</td>
<td align="right">-1.37</td>
<td>485.2K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLC#NYSE">XLC</a>)</td>
<td>The Communication Services Select Sector SPDR Fund</td>
<td align="right">84.97</td>
<td align="right">-1.16</td>
<td align="right">-1.35</td>
<td>16.0K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLB#NYSE">XLB</a>)</td>
<td>Materials Select Sector SPDR</td>
<td align="right">73.58</td>
<td align="right">-0.69</td>
<td align="right">-0.93</td>
<td>39.3K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>)</td>
<td>SPDR Select Sector Fund - Utilities</td>
<td align="right">72.52</td>
<td align="right">-0.57</td>
<td align="right">-0.78</td>
<td>50.4K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLP#NYSE">XLP</a>)</td>
<td>SPDR Select Sector Fund - Consumer Staples</td>
<td align="right">75.88</td>
<td align="right">-0.47</td>
<td align="right">-0.62</td>
<td>26.5K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>)</td>
<td>SPDR Select Sector Fund - Financial</td>
<td align="right">43.65</td>
<td align="right">-0.27</td>
<td align="right">-0.62</td>
<td>795.5K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLI#NYSE">XLI</a>)</td>
<td>SPDR Select Sector Fund - Industrial</td>
<td align="right">115.76</td>
<td align="right">-0.66</td>
<td align="right">-0.57</td>
<td>139.4K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>)</td>
<td>SPDR Select Sector Fund - Consumer Discretionary</td>
<td align="right">175.42</td>
<td align="right">-0.92</td>
<td align="right">-0.53</td>
<td>27.8K</td>
</tr>
</tbody>
</table>
<a href="https://pro.benzinga.com/?utm_source=insights">Pulled from Benzinga Pro data</a> this sector movers alert provides traders with a compiled way to read macro-level market trends. Investors garner a particular interest in sector movers to better determine sectors that are over- or under-performing to make better investing decisions on exchange-traded funds (ETFs) or individual tickers in those sectors. 
For more information on sector movers, <a href="https://www.benzinga.com/movers">click here</a>.

Sector ETFs

Pre-Market Outlook

Movers

XLRE

Select Sector SPDR-Consumer Discretionary

Leading And Lagging Sectors For April 9, 2025

Mizuho analyst Nitin Kumar maintains Devon Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DVN#NYSE">DVN</a>) with a Outperform and lowers the price target from $49 to $46.

Mizuho Maintains Outperform on Devon Energy, Lowers Price Target to $46

Guidance

PacBio Sees Prelim. Q1 Revenue $36.9M, Reiterates 2025 Revenue Guidance

Needham analyst Mike Matson reiterates Merit Medical Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MMSI#NASDAQ">MMSI</a>) with a Buy and maintains $116 price target.

MMSI

Needham Reiterates Buy on Merit Medical Systems, Maintains $116 Price Target

<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="900" height="600" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/09065053/Microvast-0409-01-900x600-1.png" alt="" class="wp-image-10063" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/09065053/Microvast-0409-01-900x600-1.png 900w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/09065053/Microvast-0409-01-900x600-1-300x200.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/09065053/Microvast-0409-01-900x600-1-768x512.png 768w" sizes="(max-width: 900px) 100vw, 900px" /></figure>
The EV battery maker reported a huge increase in its gross profit margin last year, a significant achievement that can help it stand out in a crowded field
<h4 class="wp-block-heading">Key Takeaways:</h4>
<ul>
<li>Microvast's gross profit margin jumped to 31.5% in 2024 from 18.7% the prior year, already exceeding the company's target for this year</li>
<li>The U.S.-based EV battery maker is reducing its reliance on China by boosting its sales to other markets, which is also helping to beef up its margins</li>
</ul>
Turbocharged margins are driving electric-vehicle (EV) battery maker&nbsp;Microvast Holdings Inc.&nbsp;(MVST.US) ahead at full speed on its journey to profitability.
The company's revenue increased about 8% year-on-year in the fourth quarter to $113.4 million, according to its&nbsp;<a href="https://www.globenewswire.com/news-release/2025/03/31/3052829/0/en/Microvast-Reports-2024-Financial-Results.html">latest earnings disclosure</a>&nbsp;last week. That kind of top-line growth isn't going to awe anyone, even though its revenue for the quarter was a record. For all 2024, Microvast's revenue grew by a more respectable 24% to $379.8 million, also a record.
What's more remarkable is a drastic improvement in Microvast's gross profit margin, which jumped to 36.6% in last year's fourth quarter from 22% a year earlier. That paralleled its performance for the entire year, when the figure jumped to 31.5% from 18.7%, surpassing its goal of hitting 30% this year. The big margin improvements led to an 80% year-on-year surge in Microvast's gross profit for the fourth quarter and a 52% rise for 2024.
Microvast is based in the U.S. state of Texas but has strong ties to China – something it is apparently trying to downplay, which looks prudent as U.S.-China trade tensions continue to rise. Its founder is a Chinese American, and China is the biggest customer for its batteries. The company also manufactures its products in China, though it wants to shift some production to a U.S. facility in the state of Tennessee if and when it raises necessary funding. It has a plant in Germany as well.
Margins can go up and down all the time, but the large improvement Microvast is reporting isn't something you see everyday. The company only provided a general explanation for the increase, with CFO Feriel Khambabi crediting improved operational efficiency, increased utilization and cost control on the company's earnings call.
Although the company didn't specially mention it, diversification away from China probably also played a role in the big margin improvement, as other markets overtook China to account for a majority of the company's revenue last year. Prices in Western markets for comparable products are typically higher than in China, helping a company to boost margins.
Improving margins is critical for Microvast because it operates in an extremely crowded industry where the top 10 global manufacturers, led by China's&nbsp;CATL&nbsp;(300750.SZ) and&nbsp;BYD&nbsp;(1211.HK; 002594.SZ), control nearly 90% of the market. Microvast is among the many smaller companies fighting for the remaining 10%. The company has been around for nearly two decades, showing that longevity doesn't necessarily spell big success in the fast-moving EV battery market.&nbsp;
To stand out, Microvast positions itself as an innovator focused on a niche of the market providing batteries for large vehicles. In its latest annual report for 2024, the company says its mission is to "innovate lithium-ion battery designs without relying on past technologies."
"We call this true innovation," Microvast declares in the report. "We started without preconceived notions of lithium-ion battery creation, unlike many companies that repurposed legacy technologies for new markets like electric vehicles – a process we consider product development rather than true innovation. To understand this difference is to understand what we have set out to achieve."
<h4 class="wp-block-heading">Geographic diversification</h4>
Microvast specializes in high-performance batteries for large vehicles like trucks, buses and trains. It says a key strength of its products is that they charge quickly and have longevity that eliminates the need for battery replacements during the lifecycle of a vehicle.
The company is American but also has close China connections, including its founding by Chinese American entrepreneur Wu Yang in Stafford, Texas in 2006. China is also the company's single biggest market, which isn't surprising given the country is the world's largest EV market.
But Microvast's sales elsewhere are growing, reducing its reliance on China – a step that looks especially important in the current environment of ever-increasing U.S.-China trade tensions. China accounted for more than 51% of Microvast's revenue as recently as 2023, but the figure dropped sharply to 33% last year as Europe, the Middle East and Africa (EMEA) zoomed to become its largest market accounting for about half of sales. U.S. sales also quadrupled, albeit from a small base, to reach 4%.
Heavy reliance on one country or region for sales is never good, especially if that market is China, where competition among battery makers is fierce and a prolonged economic slowdown is depressing vehicle sales. Increasing sales in the West looks prudent not only for diversification purposes, but also because sales to such markets typically carry higher margins.
Microvast may be a small player in the EV battery market, but at least in terms of margins, it beat some of its larger rivals last year. Its 31.5% gross margin for 2024 easily exceeded 24% for CATL and 19% for BYD, although the latter isn't directly comparable as it also makes cars.
While its margins may be enviable, Microvast still lags the larger companies on its bottom line. The company is losing money, and its net loss widened last year. One key factor was an impairment loss of $93 million following a decision to pause construction of the Tennessee plant due to insufficient funding. The company also recorded a large expense related to a convertible loan from its founder.
But these extraordinary factors aside, Microvast generated positive cash flow from its operations last year, something it hasn't been able to do for years. Investors clearly focused on such positives, sending Microvast shares rallying more than 50% in three days after the latest earnings release.
Microvast shares are still down more than 80% from where they traded in July 2021 when the company went public through a merger with a special purpose acquisition company (SPAC). They trade at a price-to-sales ratio of 1.8, far below 2.7 for industry leader CATL.
As a manufacturer, Microvast can obviously beef up its profit margins only so much. But if it can maintain its current level of operational profitability, it may well be able to become profitable on a net basis – something the lone analyst who follows the company on Yahoo Finance expects to happen this year. There will undoubtedly be headwinds, including Donald Trump's latest tariff bombs, which will make U.S.-China trade more costly. That could pressure Microvast's strong margins, though an ability to defend its profitability in such challenging times could also help to shore up its stock price.

Equities

Travel

Opinion

Markets

Microvast Reduces Dependence On China; Gross Margin Soars For 2024

Needham analyst Mike Matson reiterates OrthoPediatrics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KIDS#NASDAQ">KIDS</a>) with a Buy and maintains $42 price target.

KIDS

Needham Reiterates Buy on OrthoPediatrics, Maintains $42 Price Target

Wells Fargo analyst Timur Braziler upgrades Associated Banc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASB#NYSE">ASB</a>) from Equal-Weight to Overweight and lowers the price target from $27 to $26.

Comments

Mene

Notizie

Ultime notizie per Mene (OTC:MENEF) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO